Chemotherapy

Oncology·MeSH: Patient Compliance

63 drugs in development·42 companies·7 clinical trials

Drug Pipeline by Phase

Approved(35)

Drug	Company
ABRAXANE	ImmunityBio, Inc. (IBRX)
Alimta®	ELI LILLY & Co (LLY)
alymsys	Amneal Pharmaceuticals, Inc. (AMRX)
aprepitant	Mylan II B.V. (MYL)
arsenic tri	NEXUS BIOPHARMA INC (NEXS)
aveed	Endo LP (NDOI)
canalevia-ca1	Jaguar Health, Inc. (JAGX)
cinvanti	HERON THERAPEUTICS, INC. /DE/ (HRTX)
daurismo	PFIZER INC (PFE)
docetaxel	Amneal Pharmaceuticals, Inc. (AMRX)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
Erbitux	ELI LILLY & Co (LLY)
Erbitux®	ELI LILLY & Co (LLY)
krazati	BRISTOL MYERS SQUIBB CO (BMY)
MARGENZA	MACROGENICS INC (MGNX)
methotrexate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
nelarabine	NEXUS BIOPHARMA INC (NEXS)
nelarabine	Amneal Pharmaceuticals, Inc. (AMRX)
nypozi	GT Biopharma, Inc. (GTBP)
Ondif® (licensed product)	Aquestive Therapeutics, Inc. (AQST)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
paclitaxel	Mylan II B.V. (MYL)
palonosetron	Teva Pharmaceutical Industries Limited (TEVA)
pemetrexed	DR REDDYS LABORATORIES LTD (RDY)
pemfexy	EAGLE PHARMACEUTICALS, INC. (EGRX)
rolvedon	SPECTRUM PHARMACEUTICALS INC (SPPI)
sustol	HERON THERAPEUTICS, INC. /DE/ (HRTX)
syndros	Insys Therapeutics, Inc. (INSY)
testosterone	Amneal Pharmaceuticals, Inc. (AMRX)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
tykerb	Novartis AG (NVS)
valrubicin	CG Oncology, Inc. (CGON)
varubi	TESARO, Inc. (TSRO)
venetoclax	DR REDDYS LABORATORIES LTD (RDY)
zejula	TESARO, Inc. (TSRO)

Phase 3(10)

Drug	Company
apf530	HERON THERAPEUTICS, INC. /DE/ (HRTX)
doptelet	Dova Pharmaceuticals Inc. (DOVA)
fosaprepitant	HERON THERAPEUTICS, INC. /DE/ (HRTX)
ivonescimab	Summit Therapeutics Inc. (SMMT)
Nadunolimab	Merus N.V. (MRUS)
peg-g-csf	TC BioPharm (Holdings) plc (TCBWF)
peg-g-csf injection (kexing biopharmaceutical co	TC BioPharm (Holdings) plc (TCBWF)
romiplostim	AMGEN INC (AMGN)
Tab-cel (Ebvallo)	Atara Biotherapeutics, Inc. (ATRA)
Zipalertinib (CLN-081/TAS6417)	Cullinan Therapeutics, Inc. (CGEM)

Phase 2(4)

Drug	Company
halneuron	Dogwood Therapeutics, Inc. (DWTX)
LY3537021	Merus N.V. (MRUS)
son-080	SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG)
Toripalimab	Filana Therapeutics Inc. (FLNA)

Phase 1(4)

Preclinical(3)

Unknown(2)

Drug	Company
EndoPredict	MYRIAD GENETICS INC (MYGN)
HLX11	Organon & Co. (OGN)

N/A(1)

Drug	Company
OvaStem™	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Phase 1/Phase 2(2)

Drug	Company
amo959	Novartis AG (NVS)
AMO959	Novartis AG (NVS)

Phase 2/Phase 3(1)

Drug	Company
DA-020	Applied Therapeutics, Inc. (APLT)

Phase 4(1)

Drug	Company
Palmidrol	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 63 drugs in development for Chemotherapy across 42 companies.

There are 7 clinical trials targeting Chemotherapy tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.